Table 1 Baseline characteristics of patients in the validation group
Characteristics | Total (n = 27) | CRRT (n = 17) | non-CRRT (n = 10) | P value |
|---|---|---|---|---|
Body weight, kg | 17.75 (12.38, 32.40) | 19 (15, 28) | 15 (8.58, 45) | 0.372 |
Age, month | 64 (24, 114) | 65 (33.5, 113.5) | 44.5 (4.75, 117.25) | 0.436 |
Male, n (%) | 13 (48%) | 8 (47%) | 5 (50%) |  > 0.999 |
PRISM III | 2.50 (0.75, 4.50) | 1.5 (0.25, 4) | 4 (1.5, 6) | 0.296 |
CRP, mg/L | 100 (54, 160) | 89 (45.5,154) | 137 (65.75, 160) | 0.420 |
WBC, × 109 /L | 8.25 (3.99,13.70) | 8.25 (4.64,14.07) | 7.58 (3.03,14.45) | 0.673 |
PCT, ng/mL | 1.06 (0.22, 12.67) | 0.52 (0.2, 2.54) | 10.48 (0.51, 42.93) | 0.088 |
ALT, U/L | 34 (25, 57.50) | 51 (24, 60) | 30.5 (26, 74.75) | 0.739 |
TBIL, μmol/L | 20.31 (10.13,27.41) | 25.08 (9.65,31.95) | 12.80 (9.78,24.48) | 0.108 |
γ-GT, U/L | 20.50 (11.25, 96.5) | 17 (11, 82) | 63 (15.5, 135) | 0.200 |
Fib, g/L | 2.97 (2.06, 4.67) | 2.73 (1.89, 4.19) | 3.81 (2.74, 7.10) | 0.092 |
APTT, s | 39.85 (35.53, 143.15) | 80.7 (38.6, 155.6) | 36.1 (28.98, 38.25) | 0.015a |
INR | 1.39 (1.21, 1.55) | 1.37 (1.20, 1.76) | 1.40 (1.26, 147) | 0.916 |
PT, s | 15 (13.53, 17.10) | 15.35 (13.75, 19.05) | 14.8 (11.95, 16.15) | 0.444 |
PLT, × 109 /L | 161 (77,274) | 161 (83.5,255.5) | 171.5 (43.5,327.5) | 0.725 |
Cr, μmol/L | 29 (25.5, 52.6) | 29 (25, 35) | 27.8 (25.28, 62.43) | 0.598 |
BUN, mmol/L | 4.10 (2.75,8.90) | 3.90 (2.10,5.20) | 7.07 (3.75,11.00) | 0.063 |
Alb, g/L | 32.31 (29.70,38.25) | 31.58(26.60,35.62) | 34.30(31.25,40.175) | 0.120 |
Lac, mmol/L | 2.15 (1.10,2.80) | 2.5 (1.45, 3.05) | 0.9 (0.7, 2.2) | 0.061 |